Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and Multiple System Atrophy Syndrome

3,4-dihydroxyphenylacetaldehyde has been researched along with Multiple System Atrophy Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, DS; Sharabi, Y1
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P1

Reviews

1 review(s) available for 3,4-dihydroxyphenylacetaldehyde and Multiple System Atrophy Syndrome

ArticleYear
The heart of PD: Lewy body diseases as neurocardiologic disorders.
    Brain research, 2019, 01-01, Volume: 1702

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Catecholamines; Dopamine; Heart; Humans; Lewy Bodies; Lewy Body Disease; Multiple System Atrophy; Myocardium; Neuroimaging; Neurons; Parkinson Disease; Sympathetic Nervous System

2019

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Multiple System Atrophy Syndrome

ArticleYear
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease

2015